New Legacy Group, LLC - PHASEBIO PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

PHASEBIO PHARMACEUTICALS INC's ticker is PHAS and the CUSIP is 717224109. A total of 52 filers reported holding PHASEBIO PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
New Legacy Group, LLC ownership history of PHASEBIO PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$144,000
-54.7%
240,5750.0%0.29%
+145.4%
Q1 2022$318,000
-49.4%
240,5750.0%0.12%
-1.7%
Q4 2021$628,000–240,575–0.12%–
 Download
Other shareholders

There were no reported owners of PHASEBIO PHARMACEUTICALS INC in Q4 2021.

NameSharesValueWeighting ↓
View complete list of PHASEBIO PHARMACEUTICALS INC shareholders